Cited by 6RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

Development of flexible nanocarriers for siRNA delivery into tumor tissue

Open access
Jung, Hyunkyung, Shimatani, Yuri, Hasan, Mahadi, Uno, Kohei, Hama, Susumu, Kogure, Kentaro·2017·International Journal of Pharmaceutics

Abstract

Various non-viral delivery systems for small interfering RNAs (siRNA) have been developed. Such delivery systems generally exhibit tightly formed spherical structures. While such carriers have demonstrated good transfection activity in mono-layered cell systems, effects against solid tumors are often less apparent and difficult to demonstrate, likely due to the rigid structures of the carriers, which may prevent penetration to deeper regions within tumor tissue. Herein, we developed a flexible nanocarrier (FNC) system that is able to penetrate to deeper regions within tumor tissue. Specifically, we employed previously found flexible polyplexes comprised of siRNA and poly-l-lysine as wick structures for the preparation of FNCs. FNCs were constructed by coating the wick structures with lipids using a liposomal membrane fusion method. The diameters of the resulting FNCs were ca. 170nm, and the shapes were non-spherical. Lipid coating was confirmed using a nuclease resistance assay. Furthermore, FNCs showed significant RNA interference effects, comparable to Lipofectamine 2000, in a mono-layered cell system. To accelerate tumor penetration, the FNC surface was modified with polyethylene glycol (PEG) and the tight junction opener peptide AT1002. Surface-modified FNCs demonstrated effective penetrability into a cancer spheroid. Thus, we developed a novel and unique tumor-penetrable siRNA FNC system.

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2016.11.042

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Jung, H., Shimatani, Y., Hasan, M., Uno, K., Hama, S., & Kogure, K.
Affiliations
  • Kyoto Pharmaceutical University (JP)
  • Tokushima University (JP)
Corresponding author
Kogure, Kentaro
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2017-01
Volume
516
Issue
1-2
Pages
258-265
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2550479450
Cited by
6
References
0
Citations by year
2025: 2 · 2022: 2 · 2019: 1 · 2018: 1
FWCI
0.35
Type
journal article
Language
en
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Funders
  • Japan Society for the Promotion of Science (15K14945)
  • Ministry of Education, Culture, Sports, Science and Technology (S1311035)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
siRNA delivery, tumor penetration, non-viral gene delivery, poly-L-lysine, lipid coating, PEGylation, tumor spheroids, RNA interference, solid tumors
MeSH terms
Animals, Lipids, Neoplasms, Particle Size, Polyethylene Glycols, Tissue Distribution, Transfection, Gene Transfer Techniques, RNA Interference, RNA, Small Interfering, Cell Line, Tumor, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review